NCT05693896Not yet recruiting
Treating Binge Eating and Obesity Digitally in Women
Treating Binge Eating and Obesity Digitally in Women: A Feasibility Study (LISTEN Study)
Source: ClinicalTrials.gov · Last updated 10 Aug 2026
Brief summary (registry, in English)
More than 30% of Black women with obesity binge eat. Binge eating may increase the risk for the development of metabolic syndrome and binge-eating-disorder (BED), which is associated with severe obesity. Though several effective treatments for binge eating exist, Black women have not fared well. Not only has their inclusion in treatment trials been limited, but when participating, they are more likely to drop out, and/or lose less weight, compared to their White counterparts. Furthermore, treatment for binge eating is often not available in primary care and community-based settings places where Black women are more likely to receive treatment for their eating and weight-related concerns. Currently, there is scant intervention research to treat binge eating in Black women. With the highest rates of obesity (57%) nationally, Black women are in need of culturally-relevant treatments for binge eating and weight gain prevention. Given the established relationship between frequent binge eating and subsequent weight gain, addressing binge eating among Black women with obesity is imperative.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 11 Jan 2023
- Start date
- Sept 2026
- Primary completion date
- Sept 2027
- Lead sponsor
- University of North Carolina, Chapel Hill
- Diseases
- Obesity
- NCT number
- NCT05693896
What you commit to
- Study type: Interventional
- Planned participants: 60
- From Sept 2026 to the primary completion date, Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Are currently taking or have taken within the prior 3 months (12 weeks) a GLP-1,
- are concurrent intravenous drug users
Other illness
- have a history of anorexia,
Other
- currently pregnant,
- in substance abuse treatment,
- involved in another weight reduction program,
- are purging,
- currently in treatment for eating difficulties,
- consume \>4 alcoholic beverages/day
Who the study is looking for
- Over 18 years of age with pre-diabetes,
- Have an (A1c between 5.7%-6.4%),
- BMI ≥ 30 kg/m\^2,
- have and regularly use a Bluetooth-enabled smartphone,
- report at least one binge eating episode weekly,
- work or live within 30 miles of Kannapolis, NC,
- Have not used prescription weight loss medications (like Wegovy, Zepbound, or Ozempic) in the past 3 months
Age in the registry: 18 years to - · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UNC- Chapel Hill Coordinator of this site? Confirm its status | Chapel Hill | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.